Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
ProLynx
company
About
ProLynx technology is dedicated to the development of linker systems to enable predictable and controllable half-extension of drugs.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $230K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ProLynx develops advanced linker technologies and a facile with a transformative platform for controlled release of therapeutics from circulating and fixed macromolecular conjugates. The company's technology is dedicated to the development of linker systems to enable predictable and controllable half-extension of drugs.
ProLynx was founded in 2009 by Daniel V. Santi and Gary W. Ashley and is based in San Francisco, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
10
$2.26M
ProLynx has raised a total of
$2.26M
in funding over 2 rounds. Their latest funding was raised on
Jul 1, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2020 | Grant | $230K | 1 |
National Institutes of Health
|
— | Detail |
| Nov 1, 2018 | Grant | $150K | 1 |
National Institutes of Health
|
— | Detail |
| Nov 1, 2016 | Grant | $250K | 1 |
National Science Foundation
|
— | Detail |
| Jun 1, 2015 | Grant | $141.69K | 1 |
National Science Foundation
|
— | Detail |
| Nov 1, 2014 | Grant | $742.77K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
10
2
ProLynx is funded by 2 investors.
National Institutes of Health
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
